{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:32:37Z","timestamp":1794238357543,"version":"4.9.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["HLCA2024"],"award-info":[{"award-number":["HLCA2024"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019579","name":"SingHealth Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118802","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:08:46Z","timestamp":1763698126000},"page":"118802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Binding domains of \u03b1-synuclein receptors with monomeric\/oligomeric \u03b1-synuclein: Implications for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"193","author":[{"given":"Rosalie","family":"Elvira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Sheng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng-King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0251-4163","authenticated-orcid":false,"given":"Zhi Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2025.118802_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.biopha.2025.118802_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-017-0186-8","article-title":"Post translational changes to \u03b1-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson\u2019s disease","volume":"12","author":"Duce","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40478-021-01288-2","article-title":"Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro","volume":"9","author":"Marotta","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biopha.2025.118802_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010389","article-title":"The \u03b1-synuclein seeding amplification assay for Parkinson\u2019s disease","volume":"26","author":"Yi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118802_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural Transm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118802_bib7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118802_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-7-42","article-title":"Exosomal cell-to-cell transmission of alpha synuclein oligomers","volume":"7","author":"Danzer","year":"2012","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.biopha.2025.118802_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41419-019-1404-9","article-title":"Microglia as modulators of exosomal alpha-synuclein transmission","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death Dis."},{"issue":"572","key":"10.1016\/j.biopha.2025.118802_bib11","doi-asserted-by":"crossref","first-page":"eaau4543","DOI":"10.1126\/scisignal.aau4543","article-title":"Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of \u03b1-synuclein","volume":"12","author":"Harischandra","year":"2019","journal-title":"Sci. Signal."},{"issue":"18","key":"10.1016\/j.biopha.2025.118802_bib12","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","article-title":"Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes","volume":"112","author":"Scheiblich","year":"2024","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.biopha.2025.118802_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-023-05835-8","article-title":"Tunnelling nanotubes between neuronal and microglial cells allow bi-directional transfer of \u03b1-Synuclein and mitochondria","volume":"14","author":"Chakraborty","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118802_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105229","article-title":"PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats","volume":"149","author":"Thomsen","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.118802_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.stem.2023.05.015","article-title":"Advanced human iPSC-based preclinical model for Parkinson\u2019s disease with optogenetic alpha-synuclein aggregation","volume":"30","author":"Kim","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"6307","key":"10.1016\/j.biopha.2025.118802_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah3374","article-title":"Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib17","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-024-49016-3","article-title":"Aplp1 interacts with Lag3 to facilitate transmission of pathologic \u03b1-synuclein","volume":"15","author":"Mao","year":"2024","journal-title":"Nat. Commun."},{"issue":"6736","key":"10.1016\/j.biopha.2025.118802_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1126\/science.adp3645","article-title":"Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson's disease","volume":"387","author":"Wu","year":"2025","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.biopha.2025.118802_bib19","doi-asserted-by":"crossref","first-page":"eabb3063","DOI":"10.1126\/sciadv.abb3063","article-title":"The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases","volume":"6","author":"Xu","year":"2020","journal-title":"Sci. Adv."},{"issue":"8016","key":"10.1016\/j.biopha.2025.118802_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.biopha.2025.118802_bib21","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the universal protein knowledgebase in 2025","volume":"53","author":"The UniProt, C","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.biopha.2025.118802_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad1049","article-title":"Ensembl 2024","volume":"52","author":"Harrison","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118802_bib23","unstructured":"Karlsson, M., et al., A single\u2013cell type transcriptomics map of human tissues. Science Advances. 7(31): p. eabh2169."},{"issue":"5","key":"10.1016\/j.biopha.2025.118802_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107241","article-title":"The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy","volume":"300","author":"Mariuzza","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118802_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105282","article-title":"Understanding LAG-3 signaling","volume":"22","author":"Chocarro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118802_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101305","article-title":"Lymphocyte-activation gene 3 (LAG3): the next immune checkpoint receptor","volume":"42","author":"Ruffo","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biopha.2025.118802_bib27","first-page":"2025","article-title":"Neuronal LAG3 facilitates pathogenic \u03b1-synuclein neuron-to-neuron propagation","author":"Yang","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2025.118802_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.656426","article-title":"Lymphocyte activation gene 3 (Lag3) contributes to \u03b1-synucleinopathy in \u03b1-synuclein transgenic mice","volume":"15","author":"Gu","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118802_bib29","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib30","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1038\/s41598-021-90737-y","article-title":"Rapid evolution of mammalian APLP1 as a synaptic adhesion molecule","volume":"11","author":"Onodera","year":"2021","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.biopha.2025.118802_bib31","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1523\/JNEUROSCI.1875-16.2017","article-title":"APLP1 is a synaptic cell adhesion molecule, supporting maintenance of dendritic spines and basal synaptic transmission","volume":"37","author":"Schilling","year":"2017","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0169-328X(95)00328-P","article-title":"Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density","volume":"32","author":"Kim","year":"1995","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","article-title":"LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread","volume":"17","author":"Chen","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2025.118802_bib34","doi-asserted-by":"crossref","unstructured":"Stefanova, N., et al., Toll-Like Receptor 4 Promotes &,#x3b1;-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons. The American Journal of Pathology, 2011. 179(2): p. 954-963.","DOI":"10.1016\/j.ajpath.2011.04.013"},{"issue":"19","key":"10.1016\/j.biopha.2025.118802_bib35","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.15252\/embj.201591397","article-title":"\u03b1-synuclein assemblies sequester neuronal \u03b13-Na+\/K+-ATPase and impair Na+ gradient","volume":"34","author":"Shrivastava","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2025.118802_bib36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.redox.2017.11.010","article-title":"Integrin CD11b mediates \u03b1-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118802_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nbd.2015.08.025","article-title":"Fc\u03b3RIIB mediates the inhibitory effect of aggregated \u03b1-synuclein on microglial phagocytosis","volume":"83","author":"Choi","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2025.118802_bib38","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201366","article-title":"Heparan sulfate proteoglycans mediate prion-like \u03b1-synuclein toxicity in Parkinson\u2019s in vivo models","volume":"5","author":"Chen","year":"2022","journal-title":"Life Sci. Alliance"},{"issue":"11","key":"10.1016\/j.biopha.2025.118802_bib39","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/nn.4648","article-title":"\u03b1-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B","volume":"20","author":"Ferreira","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.118802_bib40","doi-asserted-by":"crossref","unstructured":"Diaz-Ortiz, M.E., et al., GPNMB confers risk for Parkinson\u2019s disease through interaction with \u03b1-synuclein. Science. 377(6608): p. eabk0637.","DOI":"10.1126\/science.abk0637"},{"issue":"26","key":"10.1016\/j.biopha.2025.118802_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011196118","article-title":"Mechanistic basis for receptor-mediated pathological \u03b1-synuclein fibril cell-to-cell transmission in Parkinson's disease","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118802_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mds.27607","article-title":"The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration","volume":"34","author":"Mor","year":"2019","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.biopha.2025.118802_bib43","doi-asserted-by":"crossref","first-page":"C836","DOI":"10.1152\/ajpcell.00639.2024","article-title":"Transmission of peripheral blood \u03b1-synuclein fibrils exacerbates synucleinopathy and neurodegeneration in Parkinson\u2019s disease by endothelial Lag3 endocytosis","volume":"328","author":"Duan","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"ement 1","key":"10.1016\/j.biopha.2025.118802_bib44","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1182\/blood-2021-147225","volume":"138","author":"Loges","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13045-024-01651-5","article-title":"Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia\/Ib study","volume":"17","author":"Mao","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"16_","key":"10.1016\/j.biopha.2025.118802_bib46","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1200\/JCO.2022.40.16_suppl.2650","article-title":"IBI110 (anti-LAG-3 mAb) as a single agent or in combination with sintilimab (anti-PD-1 mAb) in patients with advanced solid tumors: updated results from the phase Ia\/Ib dose-escalation study","volume":"40","author":"Xu","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-015-0160-z","article-title":"APLP1 as a cerebrospinal fluid biomarker for \u03b3-secretase modulator treatment","volume":"7","author":"Sj\u00f6din","year":"2015","journal-title":"Alzheimer's. Res. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2025.118802_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13238-011-1047-9","article-title":"APP and APLP1 are degraded through autophagy in response to proteasome inhibition in neuronal cells","volume":"2","author":"Zhou","year":"2011","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-025-00797-1","article-title":"Emerging targets of \u03b1-synuclein spreading in \u03b1-synucleinopathies: a review of mechanistic pathways and interventions","volume":"20","author":"Kuo","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11033-024-09520-7","article-title":"Interplay between \u03b1-synuclein and parkin genes: Insights of Parkinson\u2019s disease","volume":"51","author":"Sharma","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2025.118802_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179197","article-title":"The role of \u03b1-synuclein in etiology of neurodegenerative diseases","volume":"25","author":"Krawczuk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40035-024-00461-6","article-title":"Peripheral proteinopathy in neurodegenerative diseases","volume":"14","author":"Xu","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.biopha.2025.118802_bib53","series-title":"Microbial Data Intelligence and Computational Techniques for Sustainable Computing","first-page":"365","article-title":"AI-Assisted Methods for Protein Structure Prediction and Analysis","author":"Goel","year":"2024"},{"key":"10.1016\/j.biopha.2025.118802_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1522223","article-title":"Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology","volume":"12","author":"Dhariwal","year":"2025","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.biopha.2025.118802_bib55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40263-024-01103-1","article-title":"Alzheimer\u2019s disease: combination therapies and clinical trials for combination therapy development","volume":"38","author":"Cummings","year":"2024","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13195-020-00727-x","article-title":"Novel antibodies detect additional \u03b1-synuclein pathology in synucleinopathies: potential development for immunotherapy","volume":"12","author":"Nimmo","year":"2020","journal-title":"Alzheimer's. Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-4-7","article-title":"Progranulin in frontotemporal lobar degeneration and neuroinflammation","volume":"4","author":"Ahmed","year":"2007","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.biopha.2025.118802_bib59","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack Fernando","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118802_bib60","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jconrel.2024.12.045","article-title":"In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease models","volume":"378","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118802_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.702639","article-title":"Alpha-synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough","volume":"13","author":"Ganguly","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118802_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/brain\/awad260","article-title":"Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies","volume":"147","author":"Chopra","year":"2024","journal-title":"Brain"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:00:43Z","timestamp":1777014043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"alternative-id":["S0753332225009965"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118802","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binding domains of \u03b1-synuclein receptors with monomeric\/oligomeric \u03b1-synuclein: Implications for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118802"}}